7,4-Dimetoxiflavona

7,4′-Dimethoxyflavone: An Encyclopedic Reference

1. Identity and Chemical Characterization

1.1 Nomenclature and Classification

7,4′-Dimethoxyflavone (abbreviated 7,4′-DMF) is a member of the flavone subclass of flavonoids, which are polyphenolic secondary metabolites broadly distributed across the plant kingdom. Flavones, derived from the Latin flavus meaning "yellow," are a kind of flavonoid with a backbone of 2-phenylchromen-4-one and are well-known for their anti-cancer, anti-inflammatory, anti-microbial, antioxidant, anti-osteoporotic, anti-diabetic, anti-estrogenic, anti-allergic, and metal-chelating properties.

7,4′-Dimethoxyflavone is specifically characterized by two methoxy (–OCH₃) substituents occupying the C-7 position of the chromone A-ring and the C-4′ position of the pendant B-ring, with no free hydroxyl groups on the flavone skeleton. It carries the molecular formula C₁₇H₁₄O₄ and is registered in PubChem as Compound ID (CID) 466269. This fully methylated configuration distinguishes it from its unmethylated precursor, 7,4′-dihydroxyflavone (7,4′-DHF), and from related partially methylated analogs.

An important and closely related compound that appears repeatedly in the scientific literature is 5-hydroxy-7,4′-dimethoxyflavone — also known as acacetin 7-methyl ether — which retains a free hydroxyl group at C-5 in addition to the two methoxy groups at C-7 and C-4′. Acacetin 7-methyl ether (also known as 5-hydroxy-4′, 7-dimethoxyflavone) is a naturally occurring flavone that is present in many plants and vegetables. Much of the pharmacological literature on the 7,4′-dimethoxyflavone scaffold involves either the fully methylated form or this 5-hydroxy analog, and the two must be distinguished clearly.

1.2 Relationship to the Methoxyflavone Family

Methylated flavone derivatives — including compounds such as acacetin (5,7-dihydroxy-4′-methoxyflavone), genkwanin (4′,5-dihydroxy-7-methoxyflavone), wogonin (5,7-dihydroxy-8-methoxyflavone), and many others — constitute a broad class of plant secondary metabolites. Methylated derivatives usually show higher bioactivity, though bioactivity depends on the position of the methylated group and the number of methylated and hydroxy groups.

The structural significance of O-methylation is pharmacokinetic as well as pharmacodynamic: the methylated flavones, including 7-methoxyflavone, 7,4′-dimethoxyflavone, 5,7-dimethoxyflavone, and 5,7,4′-trimethoxyflavone, were found to be relatively stable in pooled human liver S9 fraction, indicating high resistance to hepatic metabolism. The corresponding unmethylated flavones — 7-hydroxyflavone, 7,4′-dihydroxyflavone, chrysin (5,7-dihydroxyflavone), and apigenin (5,7,4′-trihydroxyflavone) — were rapidly eliminated because of extensive glucuronidation and/or sulfation.

2. Natural Sources and Botanical Identity

2.1 Plant Species Containing 7,4′-DMF and Its Close Analogs

The 7,4′-dimethoxyflavone scaffold — both in its fully methylated and 5-hydroxy forms — has been detected and isolated from a range of medicinally significant plant species across multiple continents.

Combretum zeyheri (Large-leaved Combretum; Family Combretaceae): This species belongs to the family Combretaceae and is one of the most popular herbal plants in tropical and subtropical countries. The leaves of Combretum zeyheri have been used as herbal medicine and have been reported to have pharmacological activity including anti-bacterial, anti-fungal, anticancer, and antioxidant properties. It is from the leaf extract of this plant that 5-hydroxy-7,4′-dimethoxyflavone was isolated and characterized as a principal antifungal constituent.

Turnera diffusa (Damiana; Family Turneraceae): A series of flavonoids and flavonoid glycosides — including acacetin, acacetin 7-methyl ether (5-hydroxy-7,4′-dimethoxyflavone), vetulin, apigenin-7-O-β-d-(6-O-coumaroyl) glucoside, echinaticin, tetraphyllin B, tricin-7-glucoside, diffusavone, turneradiffusin, rhamnosylorientin, rhamnosylvitexin, and turneradin — have been isolated from T. diffusa. Damiana is a shrub native to subtropical regions of the Americas and has a long history of traditional use.

Aquilaria malaccensis (Agarwood; Family Thymelaeaceae): Fractionation of this plant's extract led to the isolation of, among other compounds, 5-hydroxy-7,4′-dimethoxyflavone, along with luteolin-7,3′,4′-trimethyl ether, luteolin-7,4′-dimethyl ether, and acacetin.

Kaempferia parviflora (Black Ginger / Thai Ginseng; Family Zingiberaceae): Although 5,7-dimethoxyflavone and 5,7,4′-trimethoxyflavone are the most characteristic methoxyflavones of this rhizome, phytochemical studies have documented the presence of related 7,4′-dimethoxylated scaffolds (such as 7,4′-dimethylapigenin) in its hexane fractions. Known commonly as Thai ginseng or black ginger, this tropical medicinal plant has been traditionally used to treat various ailments including ulcers, dysentery, gout, allergies, abscesses, and osteoarthritis. Phytochemical analysis aided by liquid chromatography–mass spectrometry led to the isolation of six methoxyflavones from the n-hexane fraction of the methanolic extract of K. parviflora rhizomes, including 7,4′-dimethylapigenin (compound 3), among others.

2.2 Common Forms and Preparations

In research settings, 7,4′-dimethoxyflavone and its close analogs are isolated from dried plant material — typically leaves or rhizomes — using solvent extraction followed by chromatographic purification. Preliminary isolation of active compounds from plant extracts is typically carried out using chromatographic techniques including Sephadex gel column chromatography, silica gel column chromatography, and thin-layer chromatography (TLC). The isolated pure compound is typically a crystalline or powder solid obtained via HPLC-guided fractionation and identified by nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry.

As a dietary supplement ingredient, 7,4′-DMF and related polymethoxyflavones (PMFs) are commercially available as standardized extracts, typically from K. parviflora or citrus sources, presented in capsule or tablet form. No specific pharmaceutical-grade monograph for isolated 7,4′-dimethoxyflavone has been established in major pharmacopeias as of the time of this writing.

3. Traditional and Historical Use

3.1 Combretum zeyheri in African Traditional Medicine

Combretum zeyheri belongs to the family Combretaceae and is one of the most popular herbal plants in tropical and subtropical countries. The leaves of Combretum zeyheri have been used as herbal medicine and have been reported to have pharmacological activity including anti-bacterial, anti-fungal, anticancer, and antioxidant properties. Within southern African ethnomedicine, various Combretum species are employed as decoctions and infusions of leaves and bark for treating infections, inflammation, and gastrointestinal ailments, though documentation of the specific use of isolated 7,4′-dimethoxyflavone compounds from the ethnobotanical record is limited — the plant is used as a whole extract rather than as an isolated phytochemical.

3.2 Turnera diffusa (Damiana) in Mesoamerican Traditional Medicine

Damiana (Turnera diffusa) is a small shrub native to Mexico, Central America, and the Caribbean. Indigenous peoples, particularly in Mexico, have used aerial parts of damiana — prepared as teas, tinctures, and smoked preparations — for centuries as an aphrodisiac, tonic, and remedy for nervousness and anxiety. The 5-hydroxy-7,4′-dimethoxyflavone (acacetin 7-methyl ether) is among the characterized flavonoid constituents of damiana, though the plant was historically used as a complex extract, not as an isolated compound.

3.3 Kaempferia parviflora in Southeast Asian Traditional Medicine

The rhizome of Kaempferia parviflora, or kra-chai-dum (in Thai), is used traditionally as a folk medicine. Preliminary cholinesterase inhibitory screening of this plant extract exhibited significant acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activities. Ethnopharmacologically, the plant rhizomes have long been used as community medicines among the hill tribe people to promote health and increase life-longevity. Polymethoxyflavones are identified as phytochemicals of the plant rhizomes with 5,7-dimethoxyflavone (DMF), 3,5,7-trimethoxyflavone (TMF), and 3,5,7,3′,4′-pentamethoxyflavone (PMF) as the main constituents. Pharmacological data indicate that the health-beneficial activities of the plant rhizomes are due to antioxidant, anti-inflammatory, antistress, hypoglycemic, hypolipidemic, and anti-obesity properties.

It is important to note that all traditional applications described above pertain to whole-plant preparations, not to isolated 7,4′-dimethoxyflavone. The compound as an isolated entity is a modern research and commercial supplement construct.

4. Key Constituents and Established Mechanisms of Action

4.1 The 7,4′-Dimethoxyflavone Scaffold and Structure–Activity Relationships

The biological activity of 7,4′-DMF stems primarily from its flavone skeleton, the positions and substitution pattern of its two methoxy groups, and the consequent influence on its interactions with enzymes and receptors. Methylated derivatives usually show higher bioactivity, but bioactivity depends on the position of the methylated group and the number of methylated and hydroxy groups.

A key mechanistic advantage of full O-methylation at C-7 and C-4′ is the elimination of the free hydroxyl groups that would otherwise undergo rapid phase II conjugation (glucuronidation and sulfation) in the liver and intestinal wall. The crucial feature of flavonoids in respect to metabolism is their unprotected hydroxyl groups, which are rapidly and efficiently metabolized via glucuronidation and sulfation. Recent studies demonstrated that several methylated flavones are potent inhibitors of carcinogen-bioactivating enzymes in a variety of human epithelial cells, and these methylated flavones are resistant to metabolic inactivation as compared to the analogous unmethylated flavones.

4.2 Aromatase (CYP19) Inhibition

The most extensively documented mechanism for 7,4′-dimethoxyflavone specifically is inhibition of the cytochrome P450 enzyme aromatase (CYP19), the rate-limiting enzyme in the conversion of androgens to estrogens. The enzyme aromatase (cytochrome P450 (CYP)19), an important regulator of estrogen hormone availability, has become a target for new drug synthesis of inhibitors attempting to treat estrogen hormone-dependent cancers, which in addition to breast cancer now also includes lung cancer.

Previous studies established chrysin, 7-hydroxyflavone, and 7,4′-dihydroxyflavone as the most potent flavonoid inhibitors of aromatase. However, very poor oral bioavailability is a major limitation for the successful use of dietary flavonoids as chemopreventive agents. This observation motivated the study of methylated analogs with improved pharmacokinetic profiles. Methylated flavones, including 5,7-dimethoxyflavone, 7-methoxyflavone, and 7,4′-dimethoxyflavone, were shown to be much more resistant to metabolism than their unmethylated analogs and to have much higher intestinal absorption.

The critical finding was that two methylated flavones, 7,4′-DMF and especially 7-methoxyflavone, were only slightly less potent than 7,4′-dihydroxyflavone and 7-hydroxyflavone — previously shown to be the two most potent flavone inhibitors of aromatase. The importance of this finding lies in the fact that these methylated flavones are highly stable against human hepatic metabolism.

4.3 CYP1A1 Inhibition and Carcinogen Bioactivation

Closely related methoxyflavones at the 7-position have been shown to modulate cytochrome P450 1A1 (CYP1A1), an enzyme involved in the bioactivation of procarcinogens such as benzo[a]pyrene (BaP). The objective of relevant studies was to examine the ability of dietary polyphenols to inhibit CYP1A1 expression and activity and benzo[a]pyrene DNA binding, with emphasis on prevention of chemical-induced hepatic carcinogenesis, using HepG2 cells as a model of the normal human hepatocyte for CYP1A1 cell signaling.

4.4 Monoamine Oxidase B (MAO-B) Inhibition

The 5-hydroxy-7,4′-dimethoxyflavone analog (acacetin 7-methyl ether) has been identified as a selective monoamine oxidase B inhibitor. Investigation of the constituents isolated from Turnera diffusa (damiana) for their inhibitory activities against recombinant human monoamine oxidases (MAO-A and MAO-B) in vitro identified acacetin 7-methyl ether as a potent selective inhibitor of MAO-B (IC₅₀ = 198 nM). Acacetin 7-methyl ether was four-fold less potent as an inhibitor of MAO-B when compared to acacetin (IC₅₀ = 50 nM). However, acacetin 7-methyl ether was more than 500-fold selective against MAO-B over MAO-A, compared to only two-fold selectivity shown by acacetin.

4.5 Antifungal Mechanisms

The 5-hydroxy-7,4′-dimethoxyflavone analog has been mechanistically characterized for antifungal activity. The mechanism of action as a potent antifungal agent was investigated by determining its inhibitory activity on Candida albicans drug efflux pumps using the ciprofloxacin assay, and by investigating the ability to inhibit antioxidant enzymes as well as the biosynthesis of ergosterol.

Analysis of ergosterol content from Candida albicans showed a time-dependent decrease to 91% and 63% at 16 and 24 hours respectively, in cells treated with ½ MIC of 5-hydroxy-7,4′-dimethoxyflavone. The compound also showed inhibition of both the drug efflux pumps (with IC₅₀ = 51.64 μg/mL) and the antioxidant enzymes (at 5 μM).

4.6 Anti-inflammatory Mechanisms in the Methoxyflavone Class

The anti-inflammatory and antioxidant activities of Kaempferia extract and its methoxyflavones are primarily reported to modulate several cytokines through the tyrosine kinase pathway. Related dimethoxyflavone analogs have been shown to block NF-κB translocation and suppress inducible nitric oxide synthase (iNOS) and COX-2 expression. Experimental results showed that the related compound 5,6,4′-trihydroxy-7,3′-dimethoxyflavone could block LPS-induced NF-κB translocation and iNOS and COX-2 expressions through inhibition of the mitogen-activated protein (MAP) kinase and Erk signaling pathways, suggesting this scaffold as a potent new chemopreventive anti-inflammatory agent.

5. Scientific Evidence by Area of Use

5.1 Hormone-Dependent Cancer Prevention: Aromatase Inhibition

Evidence level: Preclinical (in vitro); no human clinical trials.

It was reported that methylated flavones — including 5,7-dimethoxyflavone, 7-methoxyflavone, and 7,4′-dimethoxyflavone — are much more resistant to metabolism than their unmethylated analogs and have much higher intestinal absorption. These fully methylated flavones were examined as potential aromatase inhibitors for the prevention and/or treatment of hormone-dependent cancers. Whereas 5,7-dimethoxyflavone had poor effect compared to its unmethylated analog chrysin, 7-methoxyflavone and 7,4′-dimethoxyflavone were almost equipotent to their unmethylated analogs with IC₅₀ values of 2–9 μM.

In the study by Ta and Walle, it was revealed that methylated flavones such as 5,7-dimethoxyflavone, 7-methoxyflavone, and 7,4-dimethoxyflavone were more resistant to metabolism than unmethylated analogs and thus could inhibit the aromatase enzyme more efficiently.

In contrast to poorly bioavailable unmethylated analogs, the methylated flavones — including 7,4′-DMF — demonstrate high metabolic stability in the human liver as well as high intestinal transport, predicting high oral bioavailability. These methylated compounds thus have the potential to be effective aromatase inhibitors in humans in vivo. However, this potential has not been confirmed in human clinical trials. All aromatase inhibitory data for 7,4′-DMF is derived from cell-free enzyme assay systems (recombinant CYP19 supersomes) and cannot be extrapolated to clinical outcomes without further research.

5.2 Antifungal Activity

Evidence level: Preclinical (in vitro); no human clinical trials.

The 5-hydroxy-7,4′-dimethoxyflavone analog (Compound B) was found to be active against Candida albicans using broth dilution method, and was also found to have synergistic activity on the growth of C. albicans when combined with miconazole, completely inhibiting growth after only 4 hours of incubation.

The mechanistic studies described above (ergosterol biosynthesis inhibition and drug efflux pump inhibition) were all conducted in vitro. The observed decrease in specific activity or complete inhibition of antioxidant enzyme activity may not be entirely due to direct effects of the compound on enzymes, because 5-hydroxy-7,4′-dimethoxyflavone has been reported to have antioxidant activity and may have quenched the reactive oxygen species before C. albicans produced antioxidant enzymes. No in vivo or clinical antifungal data for these compounds exist in the peer-reviewed literature.

5.3 Neuropharmacology: MAO-B Inhibition

Evidence level: Preclinical (in vitro); no human clinical trials.

The investigation of the constituents isolated from Turnera diffusa (damiana) for their inhibitory activities against recombinant human monoamine oxidases (MAO-A and MAO-B) in vitro identified acacetin 7-methyl ether (5-hydroxy-7,4′-dimethoxyflavone) as a potent selective inhibitor of MAO-B (IC₅₀ = 198 nM).

Even though the IC₅₀ for inhibition of MAO-B by acacetin 7-methyl ether was approximately four-fold higher than that of the standard drug deprenyl (selegiline, a selective MAO-B inhibitor), acacetin 7-methyl ether's selectivity for MAO-B over MAO-A inhibition was greater than that of deprenyl. MAO-B inhibition has therapeutic relevance in neurodegenerative diseases such as Parkinson's disease, but these findings remain in vitro. No clinical data exist.

5.4 Neuroprotection and Cognitive Function (Related Methoxyflavones)

Evidence level: Preclinical (in vivo, animal); no human clinical trials specifically for 7,4′-DMF.

5,7-Dimethoxyflavone (DMF) and 5,7,4′-trimethoxyflavone are natural methoxyflavones known for their potential neuroprotective properties. Studies have investigated their mechanisms of action through in silico target predictions and in memory-impaired mice. To validate in silico findings, DMF and TMF (10/20/40 mg/kg) were administered to LPS-induced mice for 21 days. Morris Water Maze and Open Field Test were conducted to assess cognitive functions, and enzyme-linked immunosorbent assay was conducted to measure BDNF, Aβ, and pro-inflammatory markers. These studies are for 5,7-DMF, a structural analog, and no equivalent in vivo studies for 7,4′-DMF have been published in the peer-reviewed literature reviewed here.

5.5 Cholinesterase Inhibition (Related Methoxyflavones)

Evidence level: Preclinical (in vitro); no human clinical trials.

The rhizome of Kaempferia parviflora is used traditionally as a folk medicine. Preliminary cholinesterase inhibitory screening of this plant extract exhibited significant acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activities. The cholinesterase inhibitory test results showed that the highest potential inhibitors toward AChE and BChE were 5,7,4′-trimethoxyflavone and 5,7-dimethoxyflavone, respectively. The structure–activity relationship study led to the conclusion that compounds bearing 5,7-dimethoxy groups and a free substituent at C-3 had a significant inhibitory effect at a concentration of 0.1 mg/mL. 5,7-Dimethoxyflavone exhibited strong selectivity for BChE over AChE, which may be of great interest for modification as a treatment agent for Alzheimer's disease. These findings relate to structural analogs rather than 7,4′-DMF itself.

5.6 Antimicrobial Activity Broader Context

The leaves of Combretum zeyheri have been used as herbal medicine and have been reported to have pharmacological activity including anti-bacterial, anti-fungal, anticancer, and antioxidant properties. The antifungal activity of the 5-hydroxy-7,4′-dimethoxyflavone constituent from this plant extends the known antimicrobial scope of this flavone class. All evidence remains in vitro.

6. Body Systems and Health Areas of Association

• Endocrine system / Reproductive hormones: Aromatase (CYP19) inhibitory activity of 7,4′-DMF links it to hormonal regulation, particularly in the context of estrogen biosynthesis and hormone-dependent cancers (in vitro data only).
• Immune / Inflammatory system: Related dimethoxyflavone analogs modulate pro-inflammatory mediators including NF-κB, iNOS, COX-2, and MAP kinase signaling pathways (in vitro data).
• Nervous system: The 5-hydroxy-7,4′-dimethoxyflavone analog inhibits MAO-B with high selectivity, a pathway relevant to neurodegenerative disease and mood regulation (in vitro data). Related structural analogs show cholinesterase inhibitory activity and neuroprotective effects in animal models.
• Antimicrobial / Antifungal: The 5-hydroxy analog disrupts C. albicans via ergosterol biosynthesis inhibition, efflux pump suppression, and antioxidant enzyme interference (in vitro data).
• Hepatic / Metabolic: As a substrate and modulator of CYP enzymes (CYP19, CYP1A1, and potentially CYP3A4), this compound interacts with key metabolic pathways relevant to cancer chemoprevention, drug metabolism, and detoxification.
• Gastrointestinal absorption: Unlike hydroxylated flavones, fully methylated 7,4′-DMF demonstrates enhanced intestinal permeability in Caco-2 cell models, relevant to oral bioavailability.

7. Pharmacokinetics and Bioavailability

7.1 Intestinal Absorption

In a human intestinal transport model, both 7-methoxyflavone and 7,4′-dimethoxyflavone demonstrated high transport capacity compared to 7-hydroxyflavone and 7,4′-dihydroxyflavone. These data were generated using Caco-2 cells, an established in vitro model of human intestinal epithelium.

7.2 Metabolic Stability

In contrast to well-known unmethylated polyphenols such as resveratrol and quercetin, which were rapidly eliminated by the human liver S9 fraction, the methylated flavones including 7,4′-dimethoxyflavone were relatively stable, indicating high resistance to hepatic metabolism.

Importantly, not all positions of methylation confer equal stability. Of the fully methylated compounds studied with human liver microsomes, 5,7-dimethoxyflavone and 5-methoxyflavone were the most stable (intrinsic clearance 13 and 18 mL/min/kg, respectively), whereas 4′-methoxyflavone, 3′-methoxyflavone, 5,4′-dimethoxyflavone, and 7,3′-dimethoxyflavone were the least stable, emphasizing the importance of the positions of the methoxy substituents in the flavone ring system. Among five P450 isoforms tested, CYP1A1 showed the highest rate of metabolism of fully methylated compounds, followed by CYP1A2 and CYP3A4.

7.3 Tissue Distribution (Related Compounds)

While specific pharmacokinetic data for 7,4′-DMF in vivo are limited, data for related polymethoxyflavones from K. parviflora are informative. Following oral administration, concentrations of three methoxyflavones quickly approached their maximum concentration, ranging from 0.55–0.88 μg/mL, within 1–2 hours after administration, and then were gradually excreted with half-lives of 3–6 hours. The methoxyflavones showed low oral bioavailability of 1–4%. They were detected at highest levels in liver followed by kidney, and were also found in lung, testes, and brain. After absorption, organ distribution, and metabolism, the components were mainly eliminated through urine in forms of demethylated, sulfated, and glucuronidated products, and as demethylated metabolites in feces.

The contrast with unmethylated analogs is marked: methylation results in dramatically increased metabolic stability and membrane transport in the intestine and liver, thus improving oral bioavailability. The methoxyflavones also show increased cancer chemopreventive properties.

8. Dosage Forms and Doses Reported in Studies

No human clinical dosing data exist for isolated 7,4′-dimethoxyflavone. Doses described below reflect those used in preclinical research.

• Aromatase inhibition (in vitro): 7,4′-Dimethoxyflavone and 7-methoxyflavone inhibited aromatase with IC₅₀ values of 2 to 9 μM in recombinant CYP19 supersome assays.
• Antifungal activity (in vitro): 5-Hydroxy-7,4′-dimethoxyflavone showed inhibition of drug efflux pumps (IC₅₀ = 51.64 μg/mL) and antioxidant enzymes (at 5 μM).
• MAO-B inhibition (in vitro): Acacetin 7-methyl ether (5-hydroxy-4′,7-dimethoxyflavone) showed an IC₅₀ of 198 nM for MAO-B inhibition.
• Neuroprotective animal studies (related methoxyflavones): DMF and TMF were administered to LPS-induced mice at doses of 10, 20, and 40 mg/kg for 21 days.

These concentrations or doses were used solely in controlled laboratory experiments. No established human dosage has been defined by any regulatory authority or clinical trial.

9. Safety Considerations and Drug Interactions

9.1 Cytotoxicity Data

In cell-line studies with the structurally similar 3,5-dihydroxy-4′,7-dimethoxyflavone, cell viability assays showed no inhibition at concentrations ≤200 μM in THP-1 (human macrophage) and ≤80 μM in HaCaT (human keratinocyte) cell lines. Data specific to isolated 7,4′-dimethoxyflavone cytotoxicity are not available from peer-reviewed sources reviewed here.

9.2 CYP Enzyme Interactions

The most significant documented safety consideration for the 7,4′-dimethoxyflavone scaffold is its demonstrated interaction with cytochrome P450 enzymes. Because CYP1A1, CYP1A2, and CYP3A4 are all involved in the metabolism of fully methylated flavone compounds, competitive interactions with drugs metabolized by the same isoforms are plausible. CYP3A4 metabolizes a large proportion of commonly used drugs, and inhibition or induction of this enzyme by polyphenols is a well-recognized class-level interaction risk. However, no direct drug–drug interaction studies for 7,4′-DMF in humans have been reported.

9.3 Hormonal Interactions

Given the demonstrated aromatase inhibitory activity of 7,4′-DMF (IC₅₀ of 2–9 μM in vitro), concurrent use of this compound with hormone-modulating medications — including estrogen-containing products, aromatase inhibitors prescribed for breast cancer (e.g., anastrozole, letrozole), or testosterone-modulating therapies — represents a pharmacologically plausible interaction that warrants attention. Aromatase is an important regulator of estrogen hormone availability. Naturally occurring flavonoids, in particular chrysin, have been shown in vitro to be aromatase inhibitors, giving rise to claims of chrysin as a booster of testosterone levels and its marketing by health food stores and use by bodybuilders. The same narrative applies to 7,4′-DMF, though no clinical evidence confirms meaningful hormonal effects at dietary or supplemental doses.

9.4 Limitations of Current Safety Data

No formal toxicology studies, no subchronic or chronic toxicity studies, and no human safety trials specifically for isolated 7,4′-dimethoxyflavone were identified in the peer-reviewed literature. All bioactivity data derive from in vitro enzyme or cell assays and, in some cases, rodent models using related methoxyflavone analogs. Extrapolation to human safety and efficacy is therefore not supported by the currently available evidence.

10. Summary of Evidence Strength

• Aromatase inhibition: Demonstrated in vitro with IC₅₀ values of 2–9 μM; high metabolic stability rationale is compelling, but no in vivo or human data exist for 7,4′-DMF itself. Evidence is preliminary and preclinical.
• Antifungal activity (5-hydroxy analog): Demonstrated against C. albicans in vitro with mechanistic characterization (ergosterol, efflux pumps, antioxidant enzymes); no in vivo data. Evidence is preliminary and preclinical.
• MAO-B inhibition (5-hydroxy analog): Demonstrated in vitro with high selectivity; pharmacological rationale for neurological relevance is clear, but no in vivo or clinical data exist. Evidence is preliminary and preclinical.
• All other areas (neuroprotection, anti-inflammation, anticancer, metabolic): Data derive from structural analogs and class-level observations, not from 7,4′-DMF itself. Evidence for 7,4′-DMF specifically is absent or highly indirect.
• Human clinical evidence: None identified for 7,4′-dimethoxyflavone or its 5-hydroxy analog in any therapeutic area.

References

• PubChem – 7,4′-Dimethoxyflavone | C17H14O4 | CID 466269
• Mangoyi R, Midiwo J, Mukanganyama S. Isolation and characterization of an antifungal compound 5-hydroxy-7,4′-dimethoxyflavone from Combretum zeyheri. BMC Complementary Medicine and Therapies. 2015;15:378. doi:10.1186/s12906-015-0934-7
• Ta N, Walle T. Aromatase inhibition by bioavailable methylated flavones. J Steroid Biochem Mol Biol. 2007;107(1-2):127-129.
• Wen X, Walle T. Methylated flavonoids have greatly improved intestinal absorption and metabolic stability. Drug Metab Dispos. 2006;34(10):1786-1792.
• Legoabe LJ, Petzer A, Petzer JP. Selective inhibition of human monoamine oxidase B by acacetin 7-methyl ether isolated from Turnera diffusa (damiana). Molecules. 2019;24(4):810.
• Legoabe LJ, Petzer A, Petzer JP. Selective inhibition of human monoamine oxidase B by acacetin 7-methyl ether isolated from Turnera diffusa (damiana). PMC/Molecules. 2019.
• Methoxyflavones from Black Ginger (Kaempferia parviflora Wall. ex Baker) and their Inhibitory Effect on Melanogenesis in B16F10 Mouse Melanoma Cells. Plants. 2023.
• Elucidating the Neuroprotective Mechanism of 5,7-Dimethoxyflavone and 5,7′,4′-Trimethoxyflavone Through In Silico Target Prediction and in Memory-Impaired Mice. Neurochemical Research. 2025.
• The Inhibitory Mechanisms Study of 5,6,4′-Trihydroxy-7,3′-Dimethoxyflavone against LPS-Induced Macrophage Inflammatory Responses through the Antioxidant Ability. PMC. 2018.
• Ta N, Walle T. Aromatase inhibition by bioavailable methylated flavones. J Steroid Biochem Mol Biol. 2007. ScienceDirect.
• Inhibitory effect of chrysin on estrogen biosynthesis by suppression of enzyme aromatase (CYP19): A systematic review. PMC/Heliyon. 2020.
• Bioavailable Flavonoids: Cytochrome P450-Mediated Metabolism of Methoxyflavones. Drug Metabolism and Disposition. 2007.
• Tsuji PA, Winn RN, Walle T. Accumulation and metabolism of the anticancer flavonoid 5,7-dimethoxyflavone compared to its unmethylated analog chrysin in the Atlantic killifish. Chem Biol Interact. 2006;164(1-2):85-92.
• 3′-8″-Biflavones: A Review of Their Structural Diversity, Natural Occurrence, Role in Plants, Extraction and Identification. PMC. 2024.
• Phytochemical Constituents of Aquilaria malaccensis Leaf Extract and Their Anti-Inflammatory Activity against LPS/IFN-γ-Stimulated RAW 264.7 Cell Line. ACS Omega. 2022.
• Tan TYC et al. Application of Kaempferia parviflora: A Perspective Review. Natural Product Communications. 2024.
• Improvement of Damage in Human Dermal Fibroblasts by 3,5,7-Trimethoxyflavone from Black Ginger (Kaempferia parviflora). PMC. 2022.
• Anti-Skin Aging Potential of Methoxyflavones from Kaempferia parviflora Against TNF-α-Induced Oxidative Stress and Photoaging in Normal Human Dermal Fibroblasts. PMC. 2025.